Antibe Therapeutics Inc(Pre-Merger) ATBPF

We will never know

[Layth1990]

We might wake up tomorrow with partnership news, or listing. No one really knows what will happen tomorrow since those kind of news/information are kept confidential until the release.

people who sold today might regret that tomorrow, that is why it is important to hold long.If it goes down , no problem i will add more. Cheers

[MrMugsy]

Exactly ... the real money comes from holding good companies until they are sold or they have done you a great service !!!! I've never made good money by jumping around. IMO

[Doccole]

I'm a long, and I am really hoping for the best. but....I fear seeing a report that CEO Dan sold more stock, and saying "well my wife wants me to put in a trust." Dan said things would be picking up and moving in January, Dan went on this parade to encourage US investors....and we are going backwards.   Hope it's all computer trading, but I am always skeptical!

[AntibeTribe]

The real question is with who???Personally, I think big pharma (PFE, LLY or most likely given Haut, BY) partnership is the most likely scenario here. With that said, the amount of time between now and the end of q2 is looking oddly similar to the time frame of Hauts last deal.. I won't be surprised to open an email sometime this summer that says we've been acquired either!

[bringon10bagger]

I have a vision where ATE is actively negoitiating a deal and a 2nd big pharma presents a hostile takeover bid..........

[Harper75]

I've had those visions as well, although admittedly less so of late.  I'm hoping there are intense discussions being held under the corporate covers or there would be in the near future but after the last corporate update, the last catalysts for this stock appear to be either announcement of Nasdaq uplist, phase 3 commencement (with or without partnership) or and less likely outcome

[MrMugsy]

I rarely compare to the market or to another stock - it doesn't tell me anything about what I'm holding.  I try to look at the value of what I'm invested in ... and ... Phase 2 completion has opened the door to negotiations.  R&D is creating value for those discussions.  COVID has presented an extra opportunity which may or may not pan out.  Measurement at the